A combination of two diabetes drugs, metformin and rosiglitazone, was more effective in treating youth with recent-onset type 2 diabetes than metformin alone, a study funded by the National Institutes of Health (NIH) has found. Adding an intensive lifestyle intervention to metformin provided no...
The U.S. Food and Drug Administration (FDA) has announced that it will significantly restrict the use of the diabetes drug rosiglitazone (brand name, Avandia) to patients with Type 2 diabetes who cannot control their diabetes on other medications. Their decision is in response to data that...
Patients aged at least 65 years who have diabetes type 2 and take Avandia (Rosiglitazone) have a higher risk of developing stroke, heart failure, and even dying compared to similar patients who take Actos (Pioglitazone), according to a new study published in JAMA (Journal of the American Medical...